Vogenx Inc (VOGX)
NASDAQ · Manufacturing · Pharmaceutical preparations
VOGX price, last 12 months
Key stats
- Previous close
- $12.34
- Open
- $12.50
- Day range
- $11.51 – $12.85
- 52-week range
- $11.51 – $38.41
- Volume
- 144.4K
- Avg volume (20 days)
- 111.3K
- Market cap
- $247.6M
Performance
Technicals and fundamentals
About Vogenx Inc
Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $247.6M